FTO and metabolic dysfunction-associated steatotic liver disease: Following the initial discovery of FTO’s implication in human obesity, this gene has garnered significant attention in other metabolic diseases such as T2D, non-alcohol fatty liver disease (NAFLD), hypertension, cardiovascular diseases, and OP [6,7].